150.00
150.00
Inclusive of all taxes
You Save: 0. Discount 0%
Product is not available
CYFLOX 250 Tablet contains Ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic effective against a wide range of bacterial infections. Manufactured by BluepillExpress under WHO-GMP-certified facilities, CYFLOX 250 is a trusted choice for treating respiratory, urinary, gastrointestinal, and skin infections. Its rapid bactericidal action and excellent oral bioavailability make it ideal for global third-party manufacturing and pharmaceutical exports.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
CYFLOX 250 Tablet is a high-performance antibiotic formulation containing Ciprofloxacin 250mg, a potent fluoroquinolone used to treat a variety of bacterial infections. It is widely prescribed across healthcare settings for its powerful action against both gram-positive and gram-negative organisms. This includes common pathogens such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, and Salmonella species.
Ciprofloxacin operates by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination. By disrupting these processes, it leads to the death of bacterial cells, thus providing rapid clinical improvement and infection control. Its broad-spectrum coverage and bactericidal effect make CYFLOX 250 a reliable first-line or second-line treatment for various indications.
CYFLOX 250 is commonly indicated in infections of the urinary tract (UTIs), lower respiratory tract (including bronchitis and pneumonia), gastrointestinal tract (including infectious diarrhea and typhoid), skin and soft tissues, bones and joints, as well as in certain sexually transmitted infections. It is also used as prophylaxis in neutropenic patients or in individuals exposed to anthrax.
BluepillExpress ensures that each tablet of CYFLOX 250 is manufactured in world-class facilities compliant with WHO-GMP, ISO 9001, and other international quality standards. The formulation is subjected to stringent quality control measures including assay validation, dissolution profiling, microbial testing, and stability studies. Advanced packaging options such as blister and alu-alu packs are offered, customized for different regulatory regions and climates.
The standard adult dosage for CYFLOX 250 is one tablet twice daily, though this may vary depending on the infection site, severity, and patient's renal function. The product features excellent oral absorption, with high bioavailability and tissue penetration. It reaches therapeutic concentrations in most tissues, making it especially effective for hard-to-reach infections like prostatitis or osteomyelitis.
Although generally well tolerated, some individuals may experience side effects such as nausea, diarrhea, dizziness, or rash. Rare but serious side effects include tendon rupture, QT prolongation, and CNS effects, particularly in elderly patients or those with renal dysfunction. It should not be co-administered with certain medications such as theophylline or tizanidine, and should be used with caution in individuals with epilepsy or a history of tendon disorders.